These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19660607)

  • 41. Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis.
    Costa RA; Mintz GS; Carlier SG; Lansky AJ; Moussa I; Fujii K; Takebayashi H; Yasuda T; Costa JR; Tsuchiya Y; Jensen LO; Cristea E; Mehran R; Dangas GD; Iyer S; Collins M; Kreps EM; Colombo A; Stone GW; Leon MB; Moses JW
    J Am Coll Cardiol; 2005 Aug; 46(4):599-605. PubMed ID: 16098422
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients.
    Yachi S; Tanabe K; Tanimoto S; Aoki J; Nakazawa G; Yamamoto H; Otsuki S; Yagishita A; Kishi S; Nakano M; Taniwaki M; Sasaki S; Nakajima H; Mise N; Sugimoto T; Hara K
    Am J Kidney Dis; 2009 Aug; 54(2):299-306. PubMed ID: 19394736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of late incomplete stent apposition: a comparison among bare-metal stents, intracoronary radiation and sirolimus-eluting stents.
    Miyazawa A; Tsujino I; Ako J; Shimada Y; Courtney BK; Sakurai R; Nakamura M; Okura H; Waseda K; Honda Y; Fitzgerald PJ
    J Invasive Cardiol; 2007 Dec; 19(12):515-8. PubMed ID: 18180522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
    Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.
    Stone GW; Ellis SG; Cannon L; Mann JT; Greenberg JD; Spriggs D; O'Shaughnessy CD; DeMaio S; Hall P; Popma JJ; Koglin J; Russell ME;
    JAMA; 2005 Sep; 294(10):1215-23. PubMed ID: 16160130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: the nonrandomized fourth arm of the DEB-AMI (drug-eluting balloon in ST-segment elevation myocardial infarction) trial.
    Nijhoff F; Agostoni P; Belkacemi A; Nathoe HM; Voskuil M; Samim M; Doevendans PA; Stella PR
    Catheter Cardiovasc Interv; 2015 Oct; 86 Suppl 1():S34-44. PubMed ID: 26119971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intravascular ultrasound evaluation of optimal drug-eluting stent expansion after poststent balloon dilation using a noncompliant balloon versus a semicompliant balloon (from the Poststent Optimal Stent Expansion Trial [POET]).
    Kim JS; Moon JY; Ko YG; Choi D; Jang Y; Kang WC; Ahn T; Kim BK; Oh SJ; Jeon DW; Yang JY
    Am J Cardiol; 2008 Aug; 102(3):304-10. PubMed ID: 18638591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Sarno G; Lagerqvist B; Fröbert O; Nilsson J; Olivecrona G; Omerovic E; Saleh N; Venetzanos D; James S
    Eur Heart J; 2012 Mar; 33(5):606-13. PubMed ID: 22232428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravascular ultrasound comparison of the self-expanding Sideguard stent in the side branch versus a balloon-expandable stent in the main vessel to assess mechanisms of acute lumen gain in bifurcation lesions.
    Ma S; Maehara A; Hauptmann KE; Guagliumi G; Valsecchi O; Vassileva A; Appelman Y; Sangiorgi G; Prati F; Mintz GS
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):748-54. PubMed ID: 23592513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results.
    Mirabella F; Francaviglia B; Capodanno D; Di Salvo ME; Galassi AR; Ussia GP; Capranzano P; Tamburino C
    J Invasive Cardiol; 2009 Apr; 21(4):145-50. PubMed ID: 19342750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
    Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents.
    Ali ZA; Roleder T; Narula J; Mohanty BD; Baber U; Kovacic JC; Mintz GS; Otsuka F; Pan S; Virmani R; Sharma SK; Moreno P; Kini AS
    Circ Cardiovasc Interv; 2013 Oct; 6(5):507-17. PubMed ID: 24065447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequency of coronary arterial late angiographic stent thrombosis (LAST) in the first six months: outcomes with drug-eluting stents versus bare metal stents.
    Park DW; Park SW; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 2007 Mar; 99(6):774-8. PubMed ID: 17350363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon.
    de Ribamar Costa J; Mintz GS; Carlier SG; Mehran R; Teirstein P; Sano K; Liu X; Lui J; Na Y; Castellanos C; Biro S; Dani L; Rinker J; Moussa I; Dangas G; Lansky AJ; Kreps EM; Collins M; Stone GW; Moses JW; Leon MB
    Am J Cardiol; 2007 Sep; 100(5):812-7. PubMed ID: 17719325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defining a new standard for IVUS optimized drug eluting stent implantation: the PRAVIO study.
    Gerber RT; Latib A; Ielasi A; Cosgrave J; Qasim A; Airoldi F; Chieffo A; Montorfano M; Carlino M; Michev I; Tobis J; Colombo A
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):348-56. PubMed ID: 19213067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of stent under-deployment as a cause of in-stent restenosis in long stents.
    Bertrand OF; De Larochellière R; Joyal M; Bonan R; Mongrain R; Tardif JC
    Int J Cardiovasc Imaging; 2004 Aug; 20(4):279-84. PubMed ID: 15529909
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of intravascular ultrasonic imaging with versus without incomplete stent apposition at follow-up after drug-eluting stent implantation.
    Qian J; Zhang F; Wu H; Fan B; Ge L; Ge J
    Int J Cardiovasc Imaging; 2008 Feb; 24(2):133-9. PubMed ID: 17703294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.